|
市場調査レポート
商品コード
1631196
ヘリコバクターピロリ診断の市場分析レポート：タイプ別、技術別、最終用途別、地域別、セグメント別予測、2025年～2030年Helicobacter Pylori Diagnostics Market Analysis Report By Type (Instruments, Reagents, Services), By Technology (Immunoassays, POC, Molecular Diagnostics), By End Use, By Region And Segment Forecasts, 2025 - 2030 |
||||||
カスタマイズ可能
|
|||||||
価格
| ヘリコバクターピロリ診断の市場分析レポート：タイプ別、技術別、最終用途別、地域別、セグメント別予測、2025年～2030年 |
|
出版日: 2024年12月05日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
ヘリコバクターピロリ診断薬市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界のヘリコバクターピロリ診断市場規模は2025～2030年にかけてCAGR 5.87%で拡大し、2030年には9億6,619万米ドルに達すると予測されています。
費用対効果の改善と相まって、個別化された抗生物質治療に対する需要の増加がヘリコバクターピロリ（H. pylori）感染診断の成長を促進すると予測されています。
抗生物質の容易な入手と手頃な価格は、短い治療期間とともに、抗生物質の採用と前後のモニタリング検査の需要を後押しします。さらに、ピロリ菌感染症の罹患率の上昇、早期診断の必要性、診断技術における急速な技術進歩などの要因が市場の成長を促進します。しかし、極めて競合的な環境による経済的な価格維持のプレッシャーの高まりは、ヘリコバクターピロリ診断薬市場の成長を阻害する可能性があります。
ピロリ菌は好気性のグラム陰性菌で、一般に胃に存在します。胃の生態系のバランスを保つのに有利ではあるが、胃の内壁に感染を引き起こす可能性があります。この細菌は、胃がん、十二指腸潰瘍、胃炎や胃潰瘍、小腸への感染症などの原因菌の一つとして作用する可能性があります。そのため、ピロリ菌感染の早期発見を可能にするヘリコバクターピロリ診断薬の需要が高まっています。ピロリ菌による潰瘍が陽性と診断された場合、患者は10～14日間の抗生物質治療を受けることになります。ピロリ菌の治療には、メトロニダゾール、アモキシシリン、クラリスロマイシン、テトラサイクリンなどの抗生物質の併用や、プロトンポンプ阻害剤、クエン酸ラニチジンビスマス、サブサリチル酸ビスマスなどの併用があります。
イムノアッセイ技術セグメントは2018年に最大の市場シェアを占め、予測期間中に最も速いCAGRを記録すると予想されています。エンドユーザーでは、病院セグメントが2018年に最大の市場シェアを占めたが、診断ラボは今後数年間で最も速いCAGRで拡大すると予測されています。地域別では、北米がヘリコバクターピロリ診断薬の世界市場をリードしました。一方、アジア太平洋は2019～2026年にかけて最も速いCAGRを記録すると予測されています。
ヘリコバクターピロリ診断薬市場レポートハイライト
- 免疫アッセイ技術が2024年に最大の市場シェアを占め、予測期間中に最速のCAGRが見込まれます。
- エンドユーザーの中では、病院セグメントが2024年に最大の市場シェアを占め、診断ラボセグメントが2025～2030年にかけて最も速いCAGRを示すと予測されます。
- ラテンアメリカは、医療セグメントの重要性の高まり、感染症流行の増加、意識の高まりにより、予測期間中に最速CAGR 6.4％で成長すると予測されています。
目次
第1章 調査手法と範囲
第2章 エグゼクティブサマリー
第3章 市場の変数、動向、範囲
- 市場セグメンテーションと範囲
- 市場系統の展望
- 親市場の展望
- 関連/補助市場展望
- 市場動向と展望
- 市場力学
- 市場抑制要因分析
- ビジネス環境分析
- SWOT分析、要因別（政治・法律、経済技術）
- ポーターのファイブフォース分析
第4章 タイプビジネス分析
- ヘリコバクターピロリ診断市場：型変動分析
- 機器
- 機器市場、2018～2030年
- 試薬
- 試薬市場、2018～2030年
- サービス
- サービス市場、2018～2030年
第5章 技術ビジネス分析
- ヘリコバクターピロリ診断市場：技術変動分析
- 免疫アッセイ
- 免疫アッセイ市場、2018～2030年
- POC
- POC市場、2018～2030年
- 分子診断
- 分子診断市場、2018～2030年
第6章 最終用途ビジネス分析
- ヘリコバクターピロリ診断市場：最終用途変動分析
- 病院
- 病院市場、2018～2030年
- 診断ラボ
- 診断ラボ市場、2018～2030年
- クリニック
- クリニック市場、2018～2030年
第7章 地域ビジネス分析
- ヘリコバクターピロリ診断市場シェア（地域別、2024年と2030年）
- 北米
- 北米のヘリコバクターピロリ診断市場、2018～2030年
- 米国
- カナダ
- メキシコ
- 欧州
- 欧州のヘリコバクターピロリ診断市場、2018～2030年
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
- アジア太平洋
- アジア太平洋のヘリコバクターピロリ診断市場、2018～2030年
- 日本
- 中国
- インド
- 韓国
- オーストラリア
- タイ
- ラテンアメリカ
- ラテンアメリカのヘリコバクターピロリ診断市場、2018～2030年
- ブラジル
- アルゼンチン
- 中東・アフリカ
- 中東・アフリカのヘリコバクターピロリ診断市場、2018～2030年
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート
第8章 競合情勢
- 企業分類
- 戦略マッピング
- 企業市場シェア分析、2024年
- 企業プロファイル/上場企業
- Biohit Oyj
- Thermo Fisher Scientific, Inc.
- Quest Diagnostics Incorporated
- Meridian Bioscience
- Bio-Rad Laboratories
- Alpha Laboratories Ltd
- Coris BioConcept
- F. Hoffmann-La Roche AG
- Certest BIoTec
- Epitope Diagnostics, Inc.
図表
List of Tables
- Table 1 List of Secondary Sources
- Table 2 List of Abbreviations
- Table 3 Global Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 4 Global Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 5 Global Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 6 Global Helicobacter Pylori Diagnostics Market, by Region, 2018 - 2030 (USD Million)
- Table 7 North America Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
- Table 8 North America Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 9 North America Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 10 North America Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 11 U.S. Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 12 U.S. Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 13 U.S. Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 14 Mexico Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 15 Mexico Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 16 Mexico Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 17 Canada Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 18 Canada Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 19 Canada Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 20 Europe Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
- Table 21 Europe Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 22 Europe Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 23 Europe Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 24 Germany Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 25 Germany Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 26 Germany Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 27 UK Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 28 UK Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 29 UK Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 30 France Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 31 France Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 32 France Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 33 Italy Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 34 Italy Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 35 Italy Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 36 Spain Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 37 Spain Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 38 Spain Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 39 Denmark Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 40 Denmark Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 41 Denmark Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 42 Sweden Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 43 Sweden Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 44 Sweden Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 45 Norway Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 46 Norway Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 47 Norway Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 48 Asia Pacific Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
- Table 49 Asia Pacific Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 50 Asia Pacific Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 51 Asia Pacific Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 52 China Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 53 China Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 54 China Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 55 Japan Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 56 Japan Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 57 Japan Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 58 India Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 59 India Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 60 India Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 61 South Korea Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 62 South Korea Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 63 South Korea Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 64 Australia Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 65 Australia Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 66 Australia Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 67 Thailand Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 68 Thailand Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 69 Thailand Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 70 Latin America Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
- Table 71 Latin America Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 72 Latin America Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 73 Latin America Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 74 Brazil Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 75 Brazil Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 76 Brazil Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 77 Argentina Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 78 Argentina Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 79 Argentina Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 80 Middle East & Africa Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
- Table 81 Middle East & Africa Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 82 Middle East & Africa Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 83 Middle East & Africa Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 84 South Africa Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 85 South Africa Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 86 South Africa Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 87 Saudi Arabia Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 88 Saudi Arabia Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 89 Saudi Arabia Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 90 UAE Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 91 UAE Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 92 UAE Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
- Table 93 Kuwait Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
- Table 94 Kuwait Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
- Table 95 Kuwait Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information Procurement
- Fig. 3 Primary Research Pattern
- Fig. 4 Market Research Approaches
- Fig. 5 Value Chain-Based Sizing & Forecasting
- Fig. 6 Market Formulation & Validation
- Fig. 7 Helicobacter Pylori Diagnostics Market Segmentation
- Fig. 8 Market Snapshot, 2024
- Fig. 9 Market Trends & Outlook
- Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
- Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
- Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
- Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
- Fig. 14 Porter's Five Forces Analysis
- Fig. 15 Global Helicobacter Pylori Diagnostics Market: Type Movement Analysis
- Fig. 16 Global Helicobacter Pylori Diagnostics Market: for Instruments, 2018 - 2030 (USD Million)
- Fig. 17 Global Helicobacter Pylori Diagnostics Market: for Reagents, 2018 - 2030 (USD Million)
- Fig. 18 Global Helicobacter Pylori Diagnostics Market: for Services, 2018 - 2030 (USD Million)
- Fig. 19 Global Helicobacter Pylori Diagnostics Market: Technology Movement Analysis
- Fig. 20 Global Helicobacter Pylori Diagnostics Market: for Immunoassays, 2018 - 2030 (USD Million)
- Fig. 21 Global Helicobacter Pylori Diagnostics Market: for POC, 2018 - 2030 (USD Million)
- Fig. 22 Global Helicobacter Pylori Diagnostics Market: for Molecular Diagnostics, 2018 - 2030 (USD Million)
- Fig. 23 Global Helicobacter Pylori Diagnostics Market: End use Movement Analysis
- Fig. 24 Global Helicobacter Pylori Diagnostics Market: for Hospitals, 2018 - 2030 (USD Million)
- Fig. 25 Global Helicobacter Pylori Diagnostics Market: for Diagnostics Laboratories, 2018 - 2030 (USD Million)
- Fig. 26 Global Helicobacter Pylori Diagnostics Market: for Clinics, 2018 - 2030 (USD Million)
- Fig. 27 Regional Marketplace: Key Takeaways
- Fig. 28 Regional Outlook, 2024 & 2030
- Fig. 29 Global Helicobacter Pylori Diagnostics Market: Region Movement Analysis
- Fig. 30 North America Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 31 U.S. Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 32 Canada Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 33 Mexico Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 34 Europe Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 35 Germany Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 36 UK Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 37 France Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 38 Italy Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 39 Spain Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 40 Denmark Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 41 Sweden Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 42 Norway Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 43 Asia Pacific Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 44 Japan Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 45 China Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 46 India Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 47 Australia Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 48 South Korea Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 49 Thailand Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 50 Latin America Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 51 Brazil Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 52 Argentina Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 53 Middle East and Africa Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 54 South Africa Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 55 Saudi Arabia Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 56 UAE Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
- Fig. 57 Kuwait Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
目次
Product Code: GVR-3-68038-699-8
Helicobacter Pylori Diagnostics Market Growth & Trends:
The global helicobacter pylori diagnostics market size is anticipated to reach USD 966.19 million by 2030, expanding at a CAGR of 5.87% from 2025 to 2030, according to a new report by Grand View Research. Increasing demand for personalized antibiotic therapy coupled with improved cost-effectiveness Helicobacter pylori (H. pylori) infection diagnosis is projected to drive the growth.
Easy accessibility and affordability of antibiotics along with short treatment durations will boost the adoption of antibiotics as well as the demand for pre and post monitoring tests. Furthermore, factors such as rising incidence of H. pylori infections, need for early diagnosis, and rapid technological advancements in diagnostic techniques will propel the market growth. However, rising pressure of maintaining economic pricing due to the extremely competitive environment may hinder the growth of the Helicobacter pylori diagnostics market.
H. pylori is an aerobic gram-negative bacteria generally found in the stomach. Although advantageous for balancing the stomach ecology, it can cause infection to the inner stomach lining. The bacteria can act as one of the causative agents for stomach cancer, duodenal ulcers, gastritis and gastric ulcers, and infection to the small intestine, among other conditions. This has led to an increase in the demand for Helicobacter pylori diagnostics that enable early detection of H. pylori infection. Patients are subject to an antibiotic therapy for 10 to 14 days, in case of positive diagnosis of ulcers caused by this bacteria. Treatment for H. pylori could include a combination of antibiotics such as metronidazole, amoxicillin, clarithromycin, tetracycline, or with a proton pump inhibitor, ranitidine bismuth citrate, and bismuth subsalicylate.
The immunoassay technology segment held the largest market share in 2018 and is expected to register the fastest CAGR over the forecast period. In terms of end user, the hospital segment held the largest market share in 2018, while diagnostic laboratories is anticipated to expand at the fastest CAGR in the forthcoming years. In terms of region, North America led the global market for Helicobacter pylori diagnostics. Asia Pacific, on the other hand, is expected to witness the fastest CAGR from 2019 to 2026.
Helicobacter Pylori Diagnostics Market Report Highlights:
- Immunoassays technology held the largest market share in 2024 and is expected to witness the fastest CAGR over the forecast period
- Among end user, hospital segment held the largest market share in 2024, while the diagnostics laboratories segment is expected to demonstrate the fastest CAGR from 2025 to 2030
- Latin America is anticipated to grow at the fastest CAGR of 6.4% in the forecast period owing to the rising importance to the healthcare sector, increasing infectious diseases prevalence, and awareness.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Information Procurement
- 1.2. Information or Data Analysis
- 1.3. Market Scope & Segment Definition
- 1.4. Market Model
- 1.4.1. Market Study, By Company Market Share
- 1.4.2. Regional Analysis
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Segmentation and Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Trends and Outlook
- 3.4. Market Dynamics
- 3.5. Market Restraint Analysis
- 3.6. Business Environment Analysis
- 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
- 3.6.2. Porter's Five Forces Analysis
Chapter 4. Type Business Analysis
- 4.1. Helicobacter Pylori Diagnostics Market: Type Movement Analysis
- 4.2. Instruments
- 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
- 4.3. Reagents
- 4.3.1. Reagents Market, 2018 - 2030 (USD Million)
- 4.4. Services
- 4.4.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Technology Business Analysis
- 5.1. Helicobacter Pylori Diagnostics Market: Technology Movement Analysis
- 5.2. Immunoassays
- 5.2.1. Immunoassays Market, 2018 - 2030 (USD Million)
- 5.3. POC
- 5.3.1. POC Market, 2018 - 2030 (USD Million)
- 5.4. Molecular Diagnostics
- 5.4.1. Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Chapter 6. End use Business Analysis
- 6.1. Helicobacter Pylori Diagnostics Market: End use Movement Analysis
- 6.2. Hospitals
- 6.2.1. Hospitals Market, 2018 - 2030 (USD Million)
- 6.3. Diagnostics Laboratories
- 6.3.1. Diagnostics Laboratories Market, 2018 - 2030 (USD Million)
- 6.4. Clinics
- 6.4.1. Clinics Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
- 7.1. Helicobacter Pylori Diagnostics Market Share By Region, 2024 & 2030
- 7.2. North America
- 7.2.1. North America Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. Key Country Dynamics
- 7.2.2.2. Target Disease Prevalence
- 7.2.2.3. Competitive Scenario
- 7.2.2.4. Regulatory Framework
- 7.2.2.5. Reimbursement Scenario
- 7.2.2.6. U.S. Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Target Disease Prevalence
- 7.2.3.3. Competitive Scenario
- 7.2.3.4. Regulatory Framework
- 7.2.3.5. Reimbursement Scenario
- 7.2.3.6. Canada Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1. Key Country Dynamics
- 7.2.4.2. Target Disease Prevalence
- 7.2.4.3. Competitive Scenario
- 7.2.4.4. Regulatory Framework
- 7.2.4.5. Reimbursement Scenario
- 7.2.4.6. Mexico Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.3.2. Germany
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Target Disease Prevalence
- 7.3.2.3. Competitive Scenario
- 7.3.2.4. Regulatory Framework
- 7.3.2.5. Reimbursement Scenario
- 7.3.2.6. Germany Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.3.3. UK
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Target Disease Prevalence
- 7.3.3.3. Competitive Scenario
- 7.3.3.4. Regulatory Framework
- 7.3.3.5. Reimbursement Scenario
- 7.3.3.6. UK Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.3.4. France
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Target Disease Prevalence
- 7.3.4.3. Competitive Scenario
- 7.3.4.4. Regulatory Framework
- 7.3.4.5. Reimbursement Scenario
- 7.3.4.6. France Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.3.5. Italy
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Target Disease Prevalence
- 7.3.5.3. Competitive Scenario
- 7.3.5.4. Regulatory Framework
- 7.3.5.5. Reimbursement Scenario
- 7.3.5.6. Italy Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.3.6. Spain
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Target Disease Prevalence
- 7.3.6.3. Competitive Scenario
- 7.3.6.4. Regulatory Framework
- 7.3.6.5. Reimbursement Scenario
- 7.3.6.6. Spain Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
- 7.3.7.1. Key Country Dynamics
- 7.3.7.2. Target Disease Prevalence
- 7.3.7.3. Competitive Scenario
- 7.3.7.4. Regulatory Framework
- 7.3.7.5. Reimbursement Scenario
- 7.3.7.6. Denmark Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Target Disease Prevalence
- 7.3.8.3. Competitive Scenario
- 7.3.8.4. Regulatory Framework
- 7.3.8.5. Reimbursement Scenario
- 7.3.8.6. Sweden Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.3.9. Norway
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Target Disease Prevalence
- 7.3.9.3. Competitive Scenario
- 7.3.9.4. Regulatory Framework
- 7.3.9.5. Reimbursement Scenario
- 7.3.9.6. Norway Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.4.2. Japan
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Target Disease Prevalence
- 7.4.2.3. Competitive Scenario
- 7.4.2.4. Regulatory Framework
- 7.4.2.5. Reimbursement Scenario
- 7.4.2.6. Japan Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.4.3. China
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Target Disease Prevalence
- 7.4.3.3. Competitive Scenario
- 7.4.3.4. Regulatory Framework
- 7.4.3.5. Reimbursement Scenario
- 7.4.3.6. China Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.4.4. India
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Target Disease Prevalence
- 7.4.4.3. Competitive Scenario
- 7.4.4.4. Regulatory Framework
- 7.4.4.5. Reimbursement Scenario
- 7.4.4.6. India Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.4.5. South Korea
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Target Disease Prevalence
- 7.4.5.3. Competitive Scenario
- 7.4.5.4. Regulatory Framework
- 7.4.5.5. Reimbursement Scenario
- 7.4.5.6. South Korea Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.4.6. Australia
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Target Disease Prevalence
- 7.4.6.3. Competitive Scenario
- 7.4.6.4. Regulatory Framework
- 7.4.6.5. Reimbursement Scenario
- 7.4.6.6. Australia Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Target Disease Prevalence
- 7.4.7.3. Competitive Scenario
- 7.4.7.4. Regulatory Framework
- 7.4.7.5. Reimbursement Scenario
- 7.4.7.6. Thailand Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Target Disease Prevalence
- 7.5.2.3. Competitive Scenario
- 7.5.2.4. Regulatory Framework
- 7.5.2.5. Reimbursement Scenario
- 7.5.2.6. Brazil Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.5.3. Argentina
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Target Disease Prevalence
- 7.5.3.3. Competitive Scenario
- 7.5.3.4. Regulatory Framework
- 7.5.3.5. Reimbursement Scenario
- 7.5.3.6. Argentina Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.6. MEA
- 7.6.1. MEA Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Target Disease Prevalence
- 7.6.2.3. Competitive Scenario
- 7.6.2.4. Regulatory Framework
- 7.6.2.5. Reimbursement Scenario
- 7.6.2.6. South Africa Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Target Disease Prevalence
- 7.6.3.3. Competitive Scenario
- 7.6.3.4. Regulatory Framework
- 7.6.3.5. Reimbursement Scenario
- 7.6.3.6. Saudi Arabia Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.6.4. UAE
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Target Disease Prevalence
- 7.6.4.3. Competitive Scenario
- 7.6.4.4. Regulatory Framework
- 7.6.4.5. Reimbursement Scenario
- 7.6.4.6. UAE Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Target Disease Prevalence
- 7.6.5.3. Competitive Scenario
- 7.6.5.4. Regulatory Framework
- 7.6.5.5. Reimbursement Scenario
- 7.6.5.6. Kuwait Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Share Analysis, 2024
- 8.4. Company Profiles/Listing
- 8.4.1. Biohit Oyj
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.1.3. Collection Site Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Thermo Fisher Scientific, Inc.
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.2.3. Collection Site Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Quest Diagnostics Incorporated
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.3.3. Collection Site Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Meridian Bioscience
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.4.3. Collection Site Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Bio-Rad Laboratories
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.5.3. Collection Site Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Alpha Laboratories Ltd
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.6.3. Collection Site Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Coris BioConcept
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.7.3. Collection Site Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. F. Hoffmann-La Roche AG
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.8.3. Collection Site Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Certest Biotec
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.9.3. Collection Site Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Epitope Diagnostics, Inc.
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.10.3. Collection Site Benchmarking
- 8.4.10.4. Strategic Initiatives
- 8.4.1. Biohit Oyj
